CIPO trademark

DICERNA PHARMACEUTICALS & Design

RegisteredCIPOFigurative markClass 5Class 42

"DICERNA PHARMACEUTICALS & Design" is a figurative mark owned by Dicerna Pharmaceuticals, Inc., filed at the CIPO on November 9, 2018. It is registered and covers classes 5 and 42.

View Dicerna Pharmaceuticals, Inc. portfolioGet this data via the API
Official CIPO record
DICERNA PHARMACEUTICALS & Design trademark as filed
As filed with the CIPO
Status
Registered
Since June 15, 2022
Filed
November 9, 2018
Registered
June 15, 2022
Expires
June 15, 2032
Application no.
1929863
Registration no.
TMA1131818
Office
CIPO
Canadian Intellectual Property Office
Mark type
Figurative mark
2 classes
Ownership

Who owns DICERNA PHARMACEUTICALS & Design

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Dicerna Pharmaceuticals, Inc.

United States

55 trademarks in the portfolioView company

Representative

CPST Intellectual Property Inc.

CPST Intellectual Property Inc.

Goods and services

What the mark covers

The products and services DICERNA PHARMACEUTICALS & Design is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of various diseases, namely, rare metabolic, endocrine, cardiac, oncological, gastrointestinal, nephrological, autoimmune, and neurological diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare metabolic, endocrine, cardiac, oncological, gastrointestinal, nephrological, autoimmune, and neurological diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies.

  • Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development for the treatment of various diseases, namely rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and cancers and viral infections; scientific investigations in the fields of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and cancers and viral infections for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Registration Fee Notice Sent
  3. Registration Pending
  4. Advertised; Vol.68 Issue 3502
  5. Approval Notice Sent
  6. Approved
  7. Agent Changed; From: 92 To: 23264 / Voir Preuve au dossier/See evidence on File No. 1929863
  8. Examiner's First Report
  9. Search Recorded
  10. Formalized

2 earlier steps on the official record.

FAQ

About DICERNA PHARMACEUTICALS & Design

Who owns the trademark "DICERNA PHARMACEUTICALS & Design"?

The CIPO trademark "DICERNA PHARMACEUTICALS & Design" (application 1929863) is owned by Dicerna Pharmaceuticals, Inc.

What is the status of "DICERNA PHARMACEUTICALS & Design"?

Its status at the CIPO is: registered.

When was "DICERNA PHARMACEUTICALS & Design" registered?

It was registered on June 15, 2022 and is due to expire on June 15, 2032.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DICERNA PHARMACEUTICALS & Design and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb02-deaa-74bc-975f-084178ae33a1
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb02-deaa-74bc-975f-084178ae33a1",
  "object": "trademark",
  "mark_text": "DICERNA PHARMACEUTICALS & Design",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "1929863",
  "filing_date": "2018-11-09",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Dicerna Pharmaceuticals, Inc.",
      "entity_id": "ent_019ebbd3-862f-711a-8bfe-d2b68aad05fd"
    }
  ]
}